Inside the Numbers: Why Palantir's 85% Revenue Surge Couldn't Stop a 22% Rout

Despite 85% revenue growth and a 53% net profit margin, Palantir stock falls 22% as rising bond yields, $435M insider selling, and AI competition overshadow strong operational results.

Palantir just delivered a quarter that most software companies can only dream of. Revenue hit $1.633 billion — an 85% leap from the prior year. Net profit swelled to $870.5 million, yielding a GAAP margin of 53% that rivals the industry's elite. Yet investors have shredded the stock, sending it down more than 22% since January. The disconnect between operating reality and market sentiment has rarely been wider.

The culprit sits squarely in the bond market. US inflation data has crushed hopes of imminent rate cuts, pushing the yield on ten-year Treasuries to 4.49%. That may sound like a macroeconomic abstraction, but for richly valued equities it is a mechanical drag. Palantir trades at roughly 93 times forward earnings. When future cash flows are discounted at a higher rate, the present value shrinks — no matter how strong the current numbers.

Insider selling has added to the pressure. Over the past three months, company insiders unloaded shares worth roughly $435 million. While such sales can be routine for diversification or tax planning, the sheer scale has caught the attention of market participants. Combined with rising yields, it has sapped buying conviction.

Across the Atlantic, a data-privacy storm is brewing. Britain’s National Health Service has granted Palantir employees access to patient data under a £330 million contract signed in 2023. Critics worry about the company’s ties to the US military, and a regional health trust in Manchester has outright refused to join the platform. Palantir insists it operates only as a data processor and that any misuse would be both illegal and technically impossible. Still, the controversy risks eroding public trust — and management time.

Competitive threats are also creeping into the narrative. Developers of large language models such as OpenAI and Anthropic are increasingly positioning themselves as alternatives for enterprise customers. Palantir relies on external AI models for its platforms, leaving it exposed to potential disruption if those models become commoditized or if customers bypass Palantir entirely.

Set against those headwinds, the operational story remains compelling. The US commercial business, a key test of Palantir’s ability to expand beyond government clients, surged 133% year over year. Remaining order value hit $11.8 billion, a 98% increase. The company raised its full-year guidance and now expects 2026 revenue of around $7.66 billion, representing 71% growth from this year.

Management has pegged next-quarter revenue at roughly $1.8 billion, a figure that will serve as the next major test for the stock. Analysts are split. Argus sees the sell-off as a buying opportunity with a $190 price target. The consensus average stands at $183.73. By contrast, Morningstar warns of elevated uncertainty.

The share price has drifted perilously close to its 52-week low of around €105. At €111.28 on Thursday, the stock is trading about 20% below its 200-day moving average. For a company generating record revenue, record margins, and a growing backlog, the market is delivering a clear verdict: none of that matters if the price you pay leaves no room for error.